HOME >> MEDICINE >> NEWS
Two centres for infectious diseases established

The Netherlands Organisation for Scientific Research (NWO) has awarded a so-called centre subsidy to two research centres which are currently being established. Each centre will receive a total of 1.35 million euros. These funds must be used by the centres over the next five years to carry out multidisciplinary research towards the prevention, management or treatment of infectious diseases in the Netherlands or in developing countries. The focus is on flu, AIDS, malaria and tuberculosis.

Flu vaccine
Under the leadership of Prof. J.C. (]an) Wilschut, Departments of Medical Microbiology and Molecular Virology, University of Groningen In this centre, named NIVAREC (Netherlands Influenza Vaccine Research Centre), researchers from the University of Groningen and the Erasmus MC Rotterdam will work together with researchers from Solvay Pharmaceuticals in Weesp. The centre wants to develop and produce new flu vaccines to ensure that the Netherlands is optimally prepared for a flu pandemic.

AIDS, malaria and tuberculosis
Under the leadership of Prof. J.W.M. (Jos) van der Meer, Department of General Internal Medicine, Nijmegen University Medical Centre This centre, named PRIOR (Poverty Relationship Infection Oriented Research), forms a unique cooperation for the control of poverty-related infectious diseases in the third world. Researchers from Nijmegen University Medical Centre, Leiden University Medical Center, Universiteit Maastricht, Wageningen University and Research Centre and the National Institute of Public Health and the Environment (RIVM) will work together with colleagues in Tanzania and Indonesia. The aim is to develop a knowledge infrastructure in third world countries for poverty-related infectious diseases.

The subsidy for research centres is one of the initiatives from ZonMw (Netherlands Organisation for Health Research and Development) and NWO to stimulate research into infectious diseases. In 2002 TOPIZ,
'"/>

Contact: Sonja Jacobs
news@nwo.nl
Netherlands Organization for Scientific Research
5-Feb-2004


Page: 1 2

Related medicine news :

1. New Canadian study demonstrates clear survival benefit of treatment in trials and at large centres
2. Medically supervised injecting centres should be piloted in the UK
3. Walk-in centres perform well compared with general practice
4. High brain centres teach lower brain to adapt to injury
5. Physicians call for increased funding for federal infectious disease programs
6. Mailman School of Public Health researchers develop infectious disease diagnostic tool
7. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
8. NIAID launches program to improve medical tools against emerging infectious diseases
9. Study suggests better use of web could improve infectious disease reporting
10. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
11. The lancet infectious diseases (TLID) October press release

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two centres for infectious diseases established

(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
Cached News: